Profile
AQST ZTS TAK HLN TEVA VTRS
Company Name Aquestive Therapeutics, Inc. Zoetis Inc. Takeda Pharmaceutical Company Limited Haleon plc Teva Pharmaceutical Industries Limited Viatris Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $438.57M $79.77B $43.94B $43.92B $18.86B $15.76B
Employees 0.14K 14.10K 49.28K 25.41K 37.00K 32.00K
CEO Mr. Daniel Barber Ms. Kristin C. Peck Mr. Christophe Weber Mr. Brian James McNamara Mr. Richard D. Francis Mr. Scott Andrew Smith Ph.D.
Ratings
AQST ZTS TAK HLN TEVA VTRS
Quant Rating Score 2 3 3 3 1 3
Quant Rating Sell Neutral Neutral Neutral Strong Sell Neutral
Trading
AQST ZTS TAK HLN TEVA VTRS
Last Close $4.81 $176.81 $13.86 $9.67 $16.65 $13.2
High 52 $6.09 $199.94 $15.08 $10.69 $18.96 $13.53
Low 52 $2.01 $145.54 $12.6 $8.01 $10.44 $10.05
Price vs. 52 Week High -21.02 % -11.57 % -8.09 % -9.54 % -12.18 % -2.44 %
Price vs. 52 Week Low 139.3 % 21.49 % 10 % 20.72 % 59.48 % 31.34 %
Total Return
AQST ZTS TAK HLN TEVA VTRS
1 Month Return -12.86 % -2.82 % -0.72 % -0.62 % -9.76 % 13.6 %
3 Month Return 14.8 % -3.68 % -7.1 % -4.82 % -10.1 % 11.02 %
6 Month Return 63.61 % 2.58 % 3.74 % 14.17 % -1.94 % 24.76 %
9 Month Return 13.44 % -7.34 % -4.81 % 14.44 % 23.33 % 4.85 %
YTD Return 138.12 % -10.42 % -2.87 % 17.5 % 59.48 % 21.88 %
1 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AQST ZTS TAK HLN TEVA VTRS
Dividend Yield Percentage (TTM) - 0.98 % 4.6 % 1.64 % - 3.64 %
Dividend Paid and Capex Coverage Ration (TTM) -213.83 % 2.1 % 1.34 % - 5.06 % 2.39 %
Dividend Per Share (TTM) - 1.73 % 192 % 0.06 % - 0.48 %
Payout Ratio (TTM) - 31.44 % 101.62 % - - -65.15 %
Growth
AQST ZTS TAK HLN TEVA VTRS
Asset Growth 3.13 % -4.28 % 8.25 % -2.18 % -1.2 % -4.67 %
Gross Profit Growth 5.15 % 3.7 % 1.76 % 5.84 % 9.65 % -0.9 %
Revenue Growth 6.09 % 5.74 % 5.87 % 4.09 % 6.17 % -5.14 %
Revenue 3 Year -39.39 % 31.98 % 31.78 % 13.9 % -6.91 % -35.32 %
Revenue 5 Year -74.62 % 53.64 % 147.38 % 32.87 % -23.33 % -41.73 %
Revenue 10 Year -60.93 % 103.1 % 151.81 % 32.87 % -40.82 % -26.57 %
EBIT Growth 64.1 % 6.27 % -56.36 % 9.37 % -84.52 % -52.55 %
Net Income Growth 86.93 % 10.88 % -54.56 % -1.04 % 76.24 % -97.37 %
Net Income 3 Yeari Growth Per Share 93.39 % 47.55 % -62.13 % -8.67 % 86.29 % 104.09 %
Net Income 5 Yeari Growth Per Share 95.66 % 71.94 % 60.64 % 59.66 % 76.28 % -93.3 %
Net Income 10 Yeari Growth Per Share 67.22 % 404.24 % 34.95 % 59.66 % -133.42 % -97.12 %
Operating Income Growth 64.1 % 6.27 % -56.36 % 9.37 % -84.52 % -52.55 %
Operating Cash Flow Growth (CFG) 34.82 % 23.06 % -26.69 % 1.79 % -13.96 % -5.18 %
Operating 3 Year CFG 92.29 % 14.12 % -29.96 % 48.8 % 10.09 % 13.84 %
Operating 5 Year CFG 83.38 % 37.69 % 165.35 % 166.36 % -48.98 % -48.37 %
Operating 10 Year CFG 68.79 % 274.61 % 382.49 % 166.36 % -67.94 % -16.8 %
EPS Growth 89.52 % 12.64 % -55.38 % - 76.42 % -97.33 %
EPS Diluted Growth 89.52 % 12.92 % -54.86 % - 76.42 % -97.35 %
Book Value Per Share 28.54 % 15.25 % 12.4 % 1.35 % -7.25 % -1.92 %
Share Holder 3 Year Equity Growth Per Share -20.62 % 36.7 % 38.97 % -36.6 % -26.74 % -55.34 %
Share Holder 5 Year Equity Growth Per Share -457.43 % 139.55 % 71.52 % -39.41 % -53.44 % -27.35 %
Share Holder 10 Year Equity Growth Per Share -142.32 % 476.36 % 194.11 % -39.41 % -74.76 % 128.81 %
Dividend Per Share Growth - 15.15 % 0.92 % -85.58 % - -0.06 %
Dividend 3 Year Growth Per Share - 87.76 % 0.17 % -83.69 % - -
Dividend 5 Year Growth Per Share - 198.29 % 144.45 % -66.42 % -100 % -
Dividend 10 Year Growth Per Share - 665.58 % 101.87 % -66.42 % -100 % -
Debt Growth -40.6 % -16.5 % 24.67 % -9.43 % -6.53 % -4.64 %
Free Cash Flow Growth 40.1 % 22.25 % -31.4 % 1.67 % -19.19 % -7.35 %
Updated On 31 Dec 2023 31 Dec 2023 31 Mar 2024 31 Dec 2023 31 Dec 2023 31 Dec 2023
Profitability
AQST ZTS TAK HLN TEVA VTRS
Gross Profit Margin TTM 69.39 % 68.87 % 55.23 % 60.68 % 49.87 % 40.26 %
Return on Assets TTM -32.01 % 16.93 % 1.99 % 3.26 % -2.38 % -1.97 %
Return on Equity TTM 62.93 % 47.99 % 4.04 % 6.54 % -14.58 % -4.43 %
Return on Capital Employed TTM -22.26 % 26.36 % 4.18 % 7.22 % 7.66 % -0.71 %
Net Income Per EBT TTM 100.29 % 79.65 % 108.74 % 65.38 % 175.89 % 92.81 %
EBT Per Ebit TTM 166.29 % 91.46 % 52.35 % 82.95 % -26.34 % 359.67 %
EBIT Per Revenue TTM -35.83 % 36.45 % 11.21 % 17.82 % 12.76 % -1.76 %
Cash Flow To Debt Ratio TTM -109.38 % 44.8 % 16.58 % - 13 % 13.05 %
Receivables Turnover TTM 6.08 6.49 6.3 5.27 4.85 3.81
Payables Turnover TTM 2.38 7.05 4.92 1.23 3.55 7.23
Inventory Turnover TTM 2.57 1.18 1.69 3.03 2.13 2.2
Fixed Asset Turnover TTM 643.15 % 259.93 % 240.84 % 604.62 % 278.05 % 561.67 %
Asset Turnover TTM 53.57 % 63.75 % 31.2 % 33.71 % 40.19 % 33.6 %
Operating Cash Flow Per Share TTM -0.38 6.5 528.88 - 2.18 1.93
Free Cash Flow Per Share TTM -0.38 5.1 321.24 - 1.75 1.6
Cash Per Share TTM 85.52 % 378.45 % 57241.03 % 5.72 % 292.94 % 171.57 %
Operating Cash Flow Sales Ratio TTM -58.08 % 32.18 % 18.42 % - 14.71 % 15.29 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.47 % 78.37 % 60.74 % - 80.23 % 83.19 %
Cash Flow Coverage Ratios TTM -109.38 % 44.8 % 16.58 % - 13 % 13.05 %
Price To Free Cash Flows Ratio TTM -12.76 34.56 13.02 - 9.53 8.24
Price To Operating Cash Flows Ratio TTM -12.81 27.19 7.9 - 7.64 6.85
Price Cash Flow Ratio TTM -12.81 27.19 7.9 - 7.64 6.85
Income Statement (TTM)
AQST ZTS TAK HLN TEVA VTRS
Revenue $0.05B $8.54B $4263.76B $11.3B $15.85B $15.43B
Gross Profit $0.03B $5.83B $2832.26B $6.96B $7.65B $6.44B
Gross Profit Ratio 58.82% 68.28% 66.43% 61.59% 48.25% 41.74%
EBITDA $0B $3.69B $900.33B $2.35B $1.57B $3.46B
Net Income $-0.01B $2.34B $144.07B $1.05B $-0.56B $0.05B
EPS Diluted -0.13 5.07 91.16 0.11 -0.5 0.05
Balance Sheet (MRQ)
AQST ZTS TAK HLN TEVA VTRS
Long Term Debt $0.03B $6.75B $5029.93B $8.8B $18.48B $16.35B
Total Liabilities $0.16B $9.3B $7834.79B $17.33B $35.35B $27.22B
Total Equity $-0.11B $4.99B $7274.01B $16.73B $8.13B $20.47B
Total Investments $0B $0.02B $445.7B $0.07B $0.01B $1.33B
Total Debt $0.03B $6.76B $5463.39B $9.46B $20.15B $18.37B
Total Assets $0.06B $14.29B $15108.79B $34.06B $43.48B $47.69B
Cash Flow Statement (TTM)
AQST ZTS TAK HLN TEVA VTRS
Net Income $-0.01B $2.34B $144.07B $1.11B $-0.62B $0.05B
Inventory $-0B $-0.36B $-115.74B $-0.13B $0B $-0.61B
Dividends Paid $0B $-0.69B $-287.19B $-0.39B $0B $-0.58B
Operating Cash Flow $-0.01B $2.35B $716.34B $2.1B $1.37B $2.8B
Capital Expenditure $-0B $-0.73B $-480.73B $-0.34B $-0.53B $-0.47B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 4.41
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 1.7
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 11.61
ALVOW Alvotech 2.58
AMPH Amphastar Pharmaceuticals, Inc. 44.92
AMRX Amneal Pharmaceuticals, Inc. 8.53
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 56.87
ASRT Assertio Holdings, Inc. 0.9989
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 9.94
AYTU Aytu BioPharma, Inc. 1.5854
BDSI BioDelivery Sciences International, Inc. 5.59
ETFs With Exposure to AQST
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.01299 240.03
VTI Vanguard Total Stock Market Index Fund 0 300.43
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.0011 133.37
IWN iShares Russell 2000 Value ETF 0.01925 178.77
IWV iShares Russell 3000 ETF 0.00108 346.79
IWO iShares Russell 2000 Growth ETF 0.00705 312.71
BIB ProShares Ultra Nasdaq Biotechnology 0 58.05
VXF Vanguard Extended Market Index Fund 0.01 204.64
HDG ProShares Hedge Replication ETF 0.00196814 50.41
UWM ProShares Ultra Russell2000 0.00397681 49.77
VTHR Vanguard Russell 3000 Index Fund 0 269.51
IWC iShares Micro-Cap ETF 0.08603 136.96
DWAS Invesco DWA SmallCap Momentum ETF 0.349 101.41
URTY ProShares UltraPro Russell2000 0.00192031 64.13
VTWV Vanguard Russell 2000 Value Index Fund 0.02 157.65
GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF 0 75.54
OMFS Invesco Russell 2000 Dynamic Multifactor ETF 0.034 43.56
PTH Invesco DWA Healthcare Momentum ETF 0.439 44.2
VFMO Vanguard U.S. Momentum Factor ETF 0.1 176.74
VTWG Vanguard Russell 2000 Growth Index Fund 0.01 228
VTWO Vanguard Russell 2000 Index Fund 0.02 97.11
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 104.15
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 104.13
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 51.4
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 51.39
VBINX Vanguard Balanced Index Fund Investor Shares 0 51.38
IBBQ Invesco Nasdaq Biotechnology ETF 0 22.91
VTSAX Vanguard Total Stock Market Index Fund 0 146.23
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0 6.71
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 155.21
VITSX Vanguard Total Stock Market Index Fund 0 146.26
QQQS Invesco NASDAQ Future Gen 200 ETF 0.526 29.93
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.00023529 103.65
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 155.22
JKJ iShares Morningstar Small-Cap ETF 0 231.193
JKL iShares Morningstar Small-Cap Value ETF 0.01 172.726
VEMPX Vanguard Extended Market Index InstlPlus 0 383.03
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 274.35
RSSL Global X Funds 0.01 94.66
RFLR Innovator ETFs Trust 0.02 27.26
Unlock